Skip to main content

Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice.

Ramont L, Thoannes H, Volondat A, Chastang F, Millet MC, Maquart FX

Publication: Clin Chem Lab Med (2005) • Vol 43 • Page 1215-7PMID: 16232088View on PubMed

Purpose

The purpose of this paper was to determine the effects of frozen storage temperature and duration and hemolysis on the levels of neuron specific enolase (NSE) in serum and cerebrospinal fluid (CSF).

Conclusion

NSE levels were significantly lower than levels measured in fresh specimens when CSF was stored at -20 degrees C for 1 month or at -80 degrees C for 8 months prior to analysis, but NSE levels were unaffected by storage of serum at -80 degrees C for up to 9 months. NSE levels in serum and CSF were very strongly correlated with the hemolysis index.

Studies (2)

Purpose

The purpose of this study was to determine the effects of frozen storage and hemolysis on the measurement of NSE in CSF from patients suspected of having neurodegenerative disease. Aliquots of CSF were placed in polyethelene tubes for storage and recentrifuged before analysis. Hemolysate was prepared by lysing cells with toluene and water and vortexing.

Summary of Findings

NSE levels were 27.6% lower than initial levels when CSF was stored at -20 degrees C for 1 month prior to analysis (p<0.0001). A nonsignificant 5.3% decline in CSF NSE levels was found after 6 months of storage at -80 degrees C compared to levels in fresh specimens. NSE in CSF declined by 19.5% after 8 months of storage at -80 degrees C compared to levels in fresh specimens (p<0.0001). NSE levels in CSF were very strongly correlated with hemolysis index.
  • Biospecimens

    FluidCerebrospinal Fluid
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Other diagnoses
    Not specified
  • Platforms

    ProteinImmunoassay
    ProteinHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Suspected neurodegenerative disease
    Biospecimen Aliquots and ComponentsBiospecimen components
    12-24.9 umol/L Hb
    25-35.9 umol/L Hb
    36-47.9 umol/L Hb
    <12 umol/L Hb
    >48 umol/L Hb
    Biospecimen Aliquots and ComponentsHemolysis
    Hemolysate added
    No hemolysate added
    StorageStorage duration
    0 days
    1 month
    3 months
    6 months
    8 months
    9 months
    StorageStorage temperature
    -20 degrees C
    -80 degrees C